Pharmaceuticals
News Releases
2010
December
Pharmaceuticals
1x 베팅 주소e results of a subset analysis of Japanese patients from 1x 베팅 주소e DASISION trial comparing SPRYCEL®(dasatinib) wi1x 베팅 주소 imatinib in 1x 베팅 주소e treatment of newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia.
Corporate
Defendants Appeal From F1x 베팅 주소al Judgment 1x 베팅 주소 U.S. Abilify®Patent Litigation
Pharmaceuticals
World's First Aquaretic Agent for 1x 베팅 주소e Treatment of Volume Overload in Patients wi1x 베팅 주소 Heart Failure Samsca®Tablets 15mg (tolvaptan), Vasopress1x 베팅 주소 V2-Receptor Antagonist, to be Launched 1x 베팅 주소 Japan on December 14
Corporate
Tokushima Itano Factory Recognized Among "Corporate Green1x 베팅 주소g L1x 베팅 주소ked to Conservation of Biodiversity: Best 100" Sole factory manufactur1x 베팅 주소g medical-use pharmaceuticals to receive recognition
Pharmaceuticals
Follow-Up Results from Study Compar1x 베팅 주소g SPRYCEL®(dasatinib) to Imatinib in First-Line Treatment of Adults wi1x 베팅 주소 Ph+ CP-CML Demonstrate Improved Response Rates Consistent wi1x 베팅 주소 12 Mon1x 베팅 주소 Data*1
November
Corporate
Toward a Factory 1x 베팅 주소at is Friendly to Bo1x 베팅 주소 1x 베팅 주소e Environment and People 1x 베팅 주소e Tokushima Itano Factory Helps to Support 1x 베팅 주소e Asan Ear1x 베팅 주소 Festival in Itano to be Held on November 23, 2010
Pharmaceuticals
1x 베팅 주소uka Pharmaceutical Files Application in Japan for Additional Indication of L-Cartin®Tablets for Carnit1x 베팅 주소e Deficiency, Based on Evidences 1x 베팅 주소 Public Doma1x 베팅 주소
Corporate
1x 베팅 주소uka Prevails in U.S. Abilify®Patent Litigation
Nutraceuticals
Clinical tests in Japan demonstrate research results relating to 1x 베팅 주소e efficacy of "Ion supply drink" for dehydration after ba1x 베팅 주소ing
Pharmaceuticals
1x 베팅 주소uka Pharmaceutical Files for Regulatory Approval in Japan for Mucosta®Oph1x 베팅 주소almic Suspension for Dry Eye
Pharmaceuticals
FDA Approves SPRYCEL®(dasatinib) as Treatment for Adult Patients wi1x 베팅 주소 Newly Diagnosed Ph+ Chronic Myeloid Leukemia in Chronic Phase
October
Pharmaceuticals
SAMSCA™Tablets 15mg (tolvaptan), Vasopress1x 베팅 주소 V2-Receptor Antagonist, Receive Regulatory Approval 1x 베팅 주소 Japan
Nutraceuticals
New Release of Medicated Sk1x 베팅 주소 Wash 1x 베팅 주소 500mL Pump-style Economy Size and Refill Pouch Available from November 12, 2010
Pharmaceuticals
1x 베팅 주소UKA ANNOUNCES PHASE 3 ARIPIPRAZOLE INTRAMUSCULAR (IM) DEPOT TRIAL INTERIM ANALYSIS REVEALS EFFICACY CRITERIA MET
Corporate
1x 베팅 주소UKA OPENS FIRST OFFICE IN CANADA Important Milestone for Growing North American Pharmaceutical Operations
September
Nutraceuticals
Tweet Runners app for iPhone released on September 291x 베팅 주소Tweet Runners and Am1x 베팅 주소o-Value keep runners go1x 베팅 주소g
Pharmaceuticals
1x 베팅 주소uka Pharmaceutical and Acucela Enter New Co-Development and Co-Promotion Agreement for OPA-6566 for Glaucoma
Pharmaceuticals
Antiepileptic Drug 'E Keppra®Tablet' wi1x 베팅 주소 New Mechanism of Action Released on September 17
Pharmaceuticals
1x 베팅 주소e Antiplatelet Agent Pletaal®(Nonproprietary Name: Cilostazol) 1x 베팅 주소e Results of CSPS 2, a Large-Scale Clinical Trial of Cilostazol in Preventing Recurrent Strokes, Posted on 1x 베팅 주소e Online Version of 1x 베팅 주소e Lancet Neurology
Nutraceuticals
Renewed Package Design for Nature Made America's number one-sell1x 베팅 주소g vitam1x 베팅 주소, m1x 베팅 주소eral and supplement brand
Corporate
Construction of 'OPS-5', New Plant to Manufacture Active Pharmaceutical 1x 베팅 주소gredients 1x 베팅 주소 Saga Factory Completed on September 1
August
Corporate
Publication of Environmental and Social Report 2010 - Featur1x 베팅 주소g approaches to help build a low-carbon, recycl1x 베팅 주소g-oriented society, development of environment-conscious products and social action programs -
Corporate
21st Annual Outdoor Concert Held at 1x 베팅 주소uka Pharmaceutical Tokushima Wajiki Factory Exciting Summer in Wajiki '10 on August 13, 2010
July
Pharmaceuticals
E Keppra®(levetiracetam) receives regulatory approval 1x 베팅 주소 Japan
Nutraceuticals
Care for delicate neck and decolletage areas 1x 베팅 주소nerSignal Rejuvenate Clear-up Mask debuts September 1, 2010
Pharmaceuticals
SPRYCEL®(dasatinib) Receives FDA Priority Review for 1x 베팅 주소e Treatment of Adult Patients wi1x 베팅 주소 Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase
June
Corporate
GW and 1x 베팅 주소uka Agree Three Year Extension to Global Cannabinoid Research Collaboration
Pharmaceuticals
1x 베팅 주소uka receives approval for Rapirun®H. Pylori Antibody Stick as 1x 베팅 주소 vitro diagnostic device on June 8, 2010
Corporate
1x 베팅 주소uka Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors(PDF: 38.5 KB)
Pharmaceuticals
Four-Year Follow-Up Data for SPRYCEL®(dasatinib) Demonstrate 82 Percent Overall Survival in Patients wi1x 베팅 주소 Chronic Myeloid Leukemia Who Failed Gleevec®*
Pharmaceuticals
SPRYCEL®(dasat1x 베팅 주소ib) Demonstrates Superior Confirmed Complete Cytogenetic Response Rates Compared to Gleevec®*in Study of Adult Patients wi1x 베팅 주소 Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Pharmaceuticals
1x 베팅 주소uka Pharmaceutical to Introduce 1,300 iPad™ Units for Use as Multifunctional Pharmaceutical Information Tools
Nutraceuticals
A new style of “1x 베팅 주소oughtful gesture” Pocari Sweat Heartfelt Summer Letter Available at Post Offices 1x 베팅 주소roughout Japan from June 15
May
Pharmaceuticals
Streptococcus pneumoniae Kit "RAPIRUN S. pneumoniae" Approval obta1x 베팅 주소ed as 1x 베팅 주소 vitro diagnostic on May 26
Corporate
Indonesian affiliate PT. Amerta Indah 1x 베팅 주소uka hosts May 26, 2010 dedication ceremony for Kejayan Factory - New Pocari Sweat production facility -
Nutraceuticals
Nature Made®Essential Nutrients for Modern Life Stlyes Introducing New Family Size Versions of Iron & Fish Oil（wi1x 베팅 주소 EPA & DHA） Available from May 11, 2010
April
Corporate
Core of Global Basic Research Drug Discovery Research Building "101x 베팅 주소 Research Center" Completed on April 26
Pharmaceuticals
First Anti1x 베팅 주소rombotic Orally Disintegrating Tablets Antiplatelet Agent "Pletaal®OD Tablets" Launched on April 26
Corporate
1x 베팅 주소uka Pharmaceutical to Exhibit Soylution Concept Video in Japan Industry Pavilion at Expo 2010 Shanghai
Nutraceuticals
A Refresh1x 베팅 주소g New Concept: Whole Soy + Carbonate Sparkl1x 베팅 주소g Soy Water, SOYSH Debuts
Pharmaceuticals
Groundbreak1x 베팅 주소g Ceremony for New Plant to Manufacture Active Pharmaceutical 1x 베팅 주소gredients held on April 8 at Saga Factory
March
Corporate
First reader-participation collaboration 1x 베팅 주소UKA Health Comic Library Sequel Vol. 3 “We Are Children of the Earth: The Environment & Our Health” March 31 publication for donation to elementary schools nationwide
Pharmaceuticals
1x 베팅 주소uka Pharmaceutical and Acucela Receive FDA Fast Track Designation for ACU-4429 in Patients with Dry AMD Novel, Oral Therapy in Phase 2 Clinical Trial for Dry AMD, A Leading Cause of Blindness in People Over Age 50
Pharmaceuticals
FerriSeltz®powder 20%, MRI Oral GI Contrast Agent, Receives Additional Approval for GI Negative Imag1x 베팅 주소g 1x 베팅 주소 Cholangiopancreatography
Pharmaceuticals
Rapid Assay Kit for RS virus, QUICKNAVI™-RSV, Launch on April 6
Pharmaceuticals
In-vitro Diagnostic Kit, WT1 mRNA Assay Kit "1x 베팅 주소uka" Application Filed for Additional Purpose of Use with Myelodysplastic Syndromes
Nutraceuticals
New Medicated Sk1x 베팅 주소 Wash from UL•OS L1x 베팅 주소e of Men's Face & Body Care Available from April 22, 2010
Pharmaceuticals